MN
MNIVF.US Monash IVF Group Limited
- Market cap
- USD 156M
- P/E
- 10.0x
- P/B
- 0.97x
- ROE
- 3.0%
- Dividend yield
- 8.09%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jun 2026.
Is MNIVF.US undervalued?
Graham numberMNIVF.US trades 34.4% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Monash IVF Group Limited fundamental analysis
No fundamental analysis for Monash IVF Group Limited yet.
Monash IVF Group Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Monash IVF Group Limited
Monash IVF Group Limited engages in the provision of assisted reproductive genetic and specialist women imaging services in Australia and Southeast Asia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. The company also provides tertiary level prenatal diagnostic, ultrasound, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is headquartered in Cremorne, Australia.
Full company profileMonash IVF Group Limited financial statements
Monash IVF Group Limited annual financial statements (AUD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 184M | 192M | 214M | 255M | 269M |
| Gross Profit | 164M | 173M | 191M | 228M | 239M |
| Operating Income | 38.4M | 28.4M | 33.1M | -5.61M | 20.2M |
| EBITDA | - | - | 46.4M | 10.8M | 41.0M |
| Net Income | 25.1M | 18.4M | 21.8M | -6.53M | 7.43M |
| EPS | 0.06 | 0.05 | 0.06 | -0.02 | 0.02 |
| Balance Sheet | |||||
| Total Assets | 351M | 381M | 422M | 508M | 512M |
| Total Liabilities | 82.2M | 111M | 147M | 262M | 259M |
| Shareholders' Equity | 269M | 270M | 275M | 247M | 249M |
| Cash & Short-term Investments | 8.76M | 7.87M | 8.01M | 11.3M | 8.84M |
| Cash Flow | |||||
| Capital Expenditure | 10.0M | 11.8M | 27.8M | 21.7M | 23.8M |
| Free Cash Flow | 34.0M | 20.1M | 11.3M | 30.8M | 12.9M |
| Ratios | |||||
| ROE | 9.4% | 6.8% | 7.9% | -2.6% | 3.0% |
| ROA | 7.2% | 4.8% | 5.2% | -1.3% | 1.4% |
| Net Profit Margin | 13.7% | 9.6% | 10.2% | -2.6% | 2.8% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Monash IVF Group Limited dividends
- Dividend yield
- 8.09%
- Forward dividend
- 0.03 USD
- Payout ratio
- 72.8%
- Ex-dividend date
- Sep 3, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | AUD 5.41M | 0.01 | 72.8% |
| 2025 | - | - | - |
| 2024 | AUD 18.3M | 0.05 | - |
| 2023 | AUD 17.1M | 0.04 | 78.5% |
| 2022 | AUD 16.8M | 0.04 | 91.0% |
| 2021 | AUD 13.1M | 0.03 | 52.2% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Monash IVF Group Limited
- Insiders 13.98%
- Institutions 19.50%
- Public & others 66.52%
- Shares outstanding 390M
- Free float 303M
Monash IVF Group Limited company profile
- Company name
- Monash IVF Group Limited
- Ticker
- MNIVF.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Employees
- 892
- Fiscal year end
- June
- Address
- 510 Church Street, Cremorne, VIC, Australia, 3121
- Phone
- 61 3 9420 8235
- Website
- monashivfgroup.com.au
About Monash IVF Group Limited
Monash IVF Group Limited engages in the provision of assisted reproductive genetic and specialist women imaging services in Australia and Southeast Asia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. The company also provides tertiary level prenatal diagnostic, ultrasound, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is headquartered in Cremorne, Australia.
Monash IVF Group Limited management
8- Dr. Victoria Atkinson Afracma, Fracs, MbbsMD, CEO & Director
- Ms. Rebecca ReddenChief Operating Officer
- Mr. Birol AkdoganInterim Chief Financial Officer
- Dr. Deirdre Zander-Fox BSc. (Hons.), Dip. of Mgt, Ph.D.Chief Scientific Officer
- Ms. Rebecca DeanCompany Secretary & General Counsel
- Ms. Niki Howells-SchrammChief People Officer
- Ms. Tedd FuellChief Governance & Risk Officer
- Dr. Fleur CattrallChief Medical Officer